-
Pfizer promotes Bourla to COO
Pfizer names COO
NEW YORK — Pfizer has named Albert Bourla COO, effective Jan. 1, 2018. The promotion of Bourla, who was most recently group president of the company’s Innovative Health business, is accompanied by the promotion of two others within the company. John Young will take over Bourla’s vacated position and Angela Hwang will the role of Pfizer Essential Health group president role left open by Young’s promotion, both effective Jan. 1, 2018.